KEGG   DRUG: Drozitumab
Entry
D09888                      Drug                                   
Name
Drozitumab (USAN/INN)
Formula
C6334H9792N1700O2000S42
Exact mass
143014.5048
Mol weight
143102.52
Sequence
(Heavy chain)
EVQLVQSGGG VERPGGSLRL SCAASGFTFD DYAMSWVRQA PGKGLEWVSG INWQGGSTGY
ADSVKGRVTI SRDNAKNSLY LQMNSLRAED TAVYYCAKIL GAGRGWYFDY WGKGTTVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K
(Light chain)
SELTQDPAVS VALGQTVRIT CSGDSLRSYY ASWYQQKPGQ APVLVIYGAN NRPSGIPDRF
SGSSSGNTAS LTITGAQAED EADYYCNSAD SSGNHVVFGG GTKLTVLGQP KAAPSVTLFP
PSSEELQANK ATLVCLISDF YPGAVTVAWK ADSSPVKAGV ETTTPSKQSN NKYAASSYLS
LTPEQWKSHK SYSCQVTHEG STVEKTVAPT ECS
(Disulfide bridge: H22-H96, H148-H204, H265-H325, H371-H429, H230-H'230, H233-H'233, L21-L86, L135-L194, H224-L212)
  Type
Peptide
Efficacy
Antineoplastic, Anti-TRAIL receptor 2 antibody
  Type
Monoclonal antibody
Target
TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04115  p53 signaling pathway
hsa04210  Apoptosis
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF10B (TRAILR2, CD262)
     D09888  Drozitumab (USAN/INN)
Other DBs
CAS: 912628-39-8
PubChem: 124490605
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system